| Application number | Title of the application | Filing Date | Status |
|---|
| 06/506824 | METHOD OF INHIBITING THE LOCALIZATION OF NITROSAMINES IN SITES OF TUMOR FORMATION | Jun 21, 1983 | Abandoned |
Array
(
[id] => 2228379
[patent_doc_number] => 04571335
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-02-18
[patent_title] => 'Method of inhibiting herpetic lesions by the use of platinum coordination compounds'
[patent_app_type] => 1
[patent_app_number] => 6/505216
[patent_app_country] => US
[patent_app_date] => 1983-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1708
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/571/04571335.pdf
[firstpage_image] =>[orig_patent_app_number] => 505216
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/505216 | Method of inhibiting herpetic lesions by the use of platinum coordination compounds | Jun 16, 1983 | Issued |
Array
(
[id] => 2197505
[patent_doc_number] => 04520021
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-05-28
[patent_title] => 'Substituted caprolactam derivatives as antihypertensives'
[patent_app_type] => 1
[patent_app_number] => 6/505147
[patent_app_country] => US
[patent_app_date] => 1983-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4145
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/520/04520021.pdf
[firstpage_image] =>[orig_patent_app_number] => 505147
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/505147 | Substituted caprolactam derivatives as antihypertensives | Jun 15, 1983 | Issued |
| 06/504498 | USE OF TRICYCLODECENE-3,4,7,8-TETRACARBOXYLIC ACID DERIVATIVES AS ANTITUMOR AGENTS | Jun 14, 1983 | Abandoned |
Array
(
[id] => 2152828
[patent_doc_number] => 04517178
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-05-14
[patent_title] => 'Novel antibiotic 76-11, process for the production thereof, anticoccidiosis agent and domestic animals growth accelerator comprising the same as an effective ingredient'
[patent_app_type] => 1
[patent_app_number] => 6/502533
[patent_app_country] => US
[patent_app_date] => 1983-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7373
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/517/04517178.pdf
[firstpage_image] =>[orig_patent_app_number] => 502533
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/502533 | Novel antibiotic 76-11, process for the production thereof, anticoccidiosis agent and domestic animals growth accelerator comprising the same as an effective ingredient | Jun 12, 1983 | Issued |
Array
(
[id] => 2178291
[patent_doc_number] => 04507282
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-03-26
[patent_title] => 'High molecular weight antitumor antibiotic AN-7D'
[patent_app_type] => 1
[patent_app_number] => 6/502531
[patent_app_country] => US
[patent_app_date] => 1983-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3182
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/507/04507282.pdf
[firstpage_image] =>[orig_patent_app_number] => 502531
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/502531 | High molecular weight antitumor antibiotic AN-7D | Jun 9, 1983 | Issued |
Array
(
[id] => 2198297
[patent_doc_number] => 04542018
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-09-17
[patent_title] => 'Teichomycin A.sub.2 pure single factors 1, 2, 3, 4 and 5 and method for their production'
[patent_app_type] => 1
[patent_app_number] => 6/502043
[patent_app_country] => US
[patent_app_date] => 1983-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5697
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2070
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/542/04542018.pdf
[firstpage_image] =>[orig_patent_app_number] => 502043
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/502043 | Teichomycin A.sub.2 pure single factors 1, 2, 3, 4 and 5 and method for their production | Jun 6, 1983 | Issued |
Array
(
[id] => 2221307
[patent_doc_number] => 04628047
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-12-09
[patent_title] => 'Agent for enhancing antitumor activity of antitumor agent'
[patent_app_type] => 1
[patent_app_number] => 6/498639
[patent_app_country] => US
[patent_app_date] => 1983-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3696
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/628/04628047.pdf
[firstpage_image] =>[orig_patent_app_number] => 498639
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/498639 | Agent for enhancing antitumor activity of antitumor agent | May 26, 1983 | Issued |
| 06/498275 | DRUGS CONTAINING A PSORALENE DERIVATIVE | May 25, 1983 | Abandoned |
Array
(
[id] => 2361263
[patent_doc_number] => 04657927
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1987-04-14
[patent_title] => 'Malonato platinum compounds'
[patent_app_type] => 1
[patent_app_number] => 6/497806
[patent_app_country] => US
[patent_app_date] => 1983-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4054
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 306
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/657/04657927.pdf
[firstpage_image] =>[orig_patent_app_number] => 497806
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/497806 | Malonato platinum compounds | May 24, 1983 | Issued |
Array
(
[id] => 2144379
[patent_doc_number] => 04505925
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-03-19
[patent_title] => 'N,N-diethyl-5-methyl-2H-1-benzothiopyrano-4,3,2-cd-indazole-2-ethanamine compositions and methods for their use'
[patent_app_type] => 1
[patent_app_number] => 6/496612
[patent_app_country] => US
[patent_app_date] => 1983-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2187
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/505/04505925.pdf
[firstpage_image] =>[orig_patent_app_number] => 496612
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/496612 | N,N-diethyl-5-methyl-2H-1-benzothiopyrano-4,3,2-cd-indazole-2-ethanamine compositions and methods for their use | May 19, 1983 | Issued |
| 06/495231 | BBM-1675, A NEW ANTITUMOR ANTIBIOTIC COMPLEX | May 15, 1983 | Abandoned |
Array
(
[id] => 2165894
[patent_doc_number] => 04540575
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-09-10
[patent_title] => 'Choline oxidase inhibitor'
[patent_app_type] => 1
[patent_app_number] => 6/492272
[patent_app_country] => US
[patent_app_date] => 1983-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3633
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/540/04540575.pdf
[firstpage_image] =>[orig_patent_app_number] => 492272
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/492272 | Choline oxidase inhibitor | May 5, 1983 | Issued |
Array
(
[id] => 2145119
[patent_doc_number] => 04536517
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-08-20
[patent_title] => 'Method of treating diabetes mellitus using arylglyoxals'
[patent_app_type] => 1
[patent_app_number] => 6/488237
[patent_app_country] => US
[patent_app_date] => 1983-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6793
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/536/04536517.pdf
[firstpage_image] =>[orig_patent_app_number] => 488237
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/488237 | Method of treating diabetes mellitus using arylglyoxals | Apr 24, 1983 | Issued |
| 06/487901 | TREATMENT OF NEOPLASTIC DISEASES | Apr 21, 1983 | Abandoned |
| 06/485997 | METHOD OF INHIBITING HERPETIC LESIONS | Apr 17, 1983 | Abandoned |
| 06/485143 | 1,4-BIS(SUBSTITUTED-AMINO) -5,8-DIHYDROXY-ANTHRAQUINONES AND LEUCO BASES THEREOF | Apr 14, 1983 | Abandoned |
| 06/480979 | METHOD FOR TREATING CANCER | Mar 30, 1983 | Abandoned |
Array
(
[id] => 2304613
[patent_doc_number] => 04690935
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1987-09-01
[patent_title] => 'Inhibition of tumor growth and metastasis with calcium channel blocker compounds'
[patent_app_type] => 1
[patent_app_number] => 6/480704
[patent_app_country] => US
[patent_app_date] => 1983-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7968
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/690/04690935.pdf
[firstpage_image] =>[orig_patent_app_number] => 480704
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/480704 | Inhibition of tumor growth and metastasis with calcium channel blocker compounds | Mar 30, 1983 | Issued |
Array
(
[id] => 2144102
[patent_doc_number] => 04505895
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-03-19
[patent_title] => 'Antibiotic 273.sub.a1'
[patent_app_type] => 1
[patent_app_number] => 6/480604
[patent_app_country] => US
[patent_app_date] => 1983-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 5174
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/505/04505895.pdf
[firstpage_image] =>[orig_patent_app_number] => 480604
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/480604 | Antibiotic 273.sub.a1 | Mar 29, 1983 | Issued |